Libranza, Susa O.
HRN: 23-84-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CEFUROXIME 1.5GM (VIAL)
10/04/2023
10/11/2023
IV
1.5g
Q8hrs
UTI
Waiting Final Action
10/08/2023
METRONIDAZOLE 500MG (TAB)
10/08/2023
10/11/2023
PO
500mg
TID
Amoebiasis
Waiting Final Action